The Analysis of Tiotropium bromide and Roflumilast: Two Potent Medications for Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

The Analysis of Tiotropium bromide and Roflumilast: Two Potent Medications for Chronic Obstructive Pulmonary Disease

Published:2022-10-13 Issue: Volume: Page:
ISSN:
Container-title:2022 3rd International Symposium on Artificial Intelligence for Medicine Sciences
language:
Short-container-title:

Author:

Xu Yuanzi¹^ORCID

Affiliation:

1. University of Strathclyde, Strathclyde Institute of Pharmacy & Biomedical Sciences, United Kingdom

Publisher

ACM

Link

https://dl.acm.org/doi/pdf/10.1145/3570773.3570833

Reference50 articles.

1. Guidelines for the diagnosis and management of chronic obstructive pulmonary disease (revised version 2021);COPD Group;Chinese Journal of Tuberculosis and Respiratory Diseases,2021

2. Status and countermeasure of COPD early screening and diagnosis;Wang L.;Chinese Journal of Health Management,2022

3. GOLD. ( 2022 ). 2022 GOLD Reports. Global Initiative for Chronic Obstructive Lung Disease - GOLD. https://goldcopd.org/2022-gold-reports-2/ GOLD. (2022). 2022 GOLD Reports. Global Initiative for Chronic Obstructive Lung Disease - GOLD. https://goldcopd.org/2022-gold-reports-2/

4. Duffy , S. P. and Criner , G. J . ( 2019 ). Chronic Obstructive Pulmonary Disease: Evaluation and Management. The Medical clinics of North America, 103(3), 453–461 . Duffy, S. P. and Criner, G. J. (2019). Chronic Obstructive Pulmonary Disease: Evaluation and Management. The Medical clinics of North America, 103(3), 453–461.

5. Ritter , J. , Flower , R. , Henderson , G. , Loke , Y. K. , MacEwan , D. and Rang , H . ( 2014 ). Rang & Dale's Pharmacology . Elsevier Churchill Livingstone ., London. Ritter, J., Flower, R., Henderson, G., Loke, Y. K., MacEwan, D. and Rang, H. (2014). Rang & Dale's Pharmacology. Elsevier Churchill Livingstone., London.